Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease
Original Article
E.B. Esrick, L.E. Lehmann, A. Biffi, M. Achebe, C. Brendel, M.F. Ciuculescu, H. Daley, B. MacKinnon, E. Morris, A. Federico, D. Abriss, K. Boardman, R. Khelladi, K. Shaw, H. Negre, O. Negre, S. Nikiforow, J. Ritz, S.-Y. Pai, W.B. London, C. Dansereau, M.M. Heeney, M. Armant, J.P. Manis, and D.A. Williams
N Engl J Med 2021;384:205-215
Course summary
Available credit:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course opens:
01/20/2021
Course expires:
01/21/2023
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Saturday, January 21, 2023 - 11:59pm.

Facebook
X
LinkedIn
Forward